This EverlyWell service which is saturating TV screens with ads lately looks like it is another Theranos story. In other words the medical practicality of the test is dubious at best according to medical professionals. In other words don’t waste your money. From the article: (The emphasis is mine)

—“But what EverlyWell describes as one of its best-sellers — a test for food sensitivity — is of dubious medical value, according to experts interviewed by STAT. The $199 test promises to use a fingerprick’s worth of blood to gauge whether a person’s immune system is active against 96 common foods, including asparagus, garlic, and eggs. An immune protein called immunoglobulin G, the company’s website says, could be to blame for symptoms such headaches, stomach pain, diarrhea, and fatigue.

Other online vendors sell immunoglobulin G tests for food sensitivity as well, though none have reached EverlyWell’s degree of prominence. ALL ARE CONSIDERED LABORATORY-DEVELOPED TESTS, AND ARE THEREFORE NOT REGULATED BY THE FOOD AND DRUG ADMINISTRATION.

Yet physician groups have for years advised against using immunoglobulin G tests to evaluate for so-called food sensitivities or intolerances. And ALLERGY EXPERTS TOLD STAT THAT THE TEST IS USELESS AT BEST AND COULD EVEN CAUSE HARM IF IT LEADS CUSTOMERS TO UNNECESSARILY CUT NUTRITIOUS FOODS FROM THEIR DIET.”—

A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say

W hen Julia Cheek walked onto the set of “Shark Tank,” her five potential investors wore their trademark scowls. Yet within minutes, their demeanor changed, eyebrows raised and heads nodding as they peppered her with questions about her company, EverlyWell, and its promise to revolutionize medical diagnostics.

Share This